Drug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company’s product, in strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg, is the generic equivalent of Sunovion Pharmaceuticals Inc’s Latuda tablets.
